Comparison Overview

Amwell

VS

LUX MED

Amwell

75 State St, Floor 26, Boston, Massachusetts, US, 02109
Last Update: 2025-06-09 (UTC)
Between 800 and 900

Strong

At Amwell, weโ€™re all about making healthcare simpler, smarter, and more accessible. Our technology connects people to a range of programs including primary and specialty care, behavioral health, and chronic condition management. For almost 20 years, weโ€™ve helped improve health outcomes for millions of people around the world โ€” and weโ€™re just getting started.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 1,153
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

LUX MED

Szturmowa 2 Warszawa, 02-678, PL
Last Update: 2025-03-15 (UTC)

Strong

Between 800 and 900

LUX MED - leader and trustworthy expert We care for the health of the patients professionally and with engagement, we have been developing our business for over 20 years. Today we are the leader and expert on the private healthcare market. We take under our care both individual patients and corporate ones and their families. Out-patient activity is realized under two leading and complementary brands - LUX MED and Medycyna Rodzinna. We have an impressive network, which is created by over 1600 facilities with modern equipment throughout Poland, where we diagnose, examine and treat over 1 200 000 patients. We already have our own 114 medical centers, 1500 cooperating facilities and one of the biggest in Poland private diagnostic database. In 2010 we opened a hospital in Warsaw. We have over 8500 employees, including 4100 medical doctors of various specialties. Trust, satisfaction and health of the patients are values that we put great importance to. Meeting your expectations we are still perfecting our standards and implementing new solutions to provide constantly high quality of services, easy access to the doctors, consultations and examinations.

NAICS: 62
NAICS Definition:
Employees: 10,001+
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/amwellcorp.jpeg
Amwell
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/lux-med.jpeg
LUX MED
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
Amwell
100%
Compliance Rate
0/4 Standards Verified
LUX MED
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Amwell in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for LUX MED in 2025.

Incident History โ€” Amwell (X = Date, Y = Severity)

Amwell cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” LUX MED (X = Date, Y = Severity)

LUX MED cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/amwellcorp.jpeg
Amwell
Incidents

No Incident

https://images.rankiteo.com/companyimages/lux-med.jpeg
LUX MED
Incidents

No Incident

FAQ

Both Amwell company and LUX MED company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, LUX MED company has disclosed a higher number of cyber incidents compared to Amwell company.

In the current year, LUX MED company and Amwell company have not reported any cyber incidents.

Neither LUX MED company nor Amwell company has reported experiencing a ransomware attack publicly.

Neither LUX MED company nor Amwell company has reported experiencing a data breach publicly.

Neither LUX MED company nor Amwell company has reported experiencing targeted cyberattacks publicly.

Neither Amwell company nor LUX MED company has reported experiencing or disclosing vulnerabilities publicly.

Neither Amwell company nor LUX MED company has publicly disclosed detailed information about the number of their subsidiaries.

Amwell company employs more people globally than LUX MED company, reflecting its scale as a Hospitals and Health Care.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X